
Vilimed is a medical technology startup based in Lithuania that has developed the VILIM ball, a CE-marked medical device designed to reduce hand tremors associated with conditions like Essential Tremor and Parkinson's disease. Utilizing artificial intelligence, the device personalizes vibrational therapy to each patient, providing relief for everyday tasks such as eating and writing. The VILIM ball has shown high efficacy, with studies indicating a reduction in tremor intensity for approximately 80% of users, lasting up to four hours. The company is focused on improving the quality of life for tremor patients through innovative technology and has received certifications for safety and effectiveness, positioning itself strongly in the medical device market.

Vilimed is a medical technology startup based in Lithuania that has developed the VILIM ball, a CE-marked medical device designed to reduce hand tremors associated with conditions like Essential Tremor and Parkinson's disease. Utilizing artificial intelligence, the device personalizes vibrational therapy to each patient, providing relief for everyday tasks such as eating and writing. The VILIM ball has shown high efficacy, with studies indicating a reduction in tremor intensity for approximately 80% of users, lasting up to four hours. The company is focused on improving the quality of life for tremor patients through innovative technology and has received certifications for safety and effectiveness, positioning itself strongly in the medical device market.
Product: VILIM ball — CE-marked Class IIa handheld device using vibration + AI to reduce hand tremors
Clinical impact: Studies/post-market data report tremor intensity reduction for ~80% of users lasting up to four hours
Location & size: Kaunas, Lithuania; ~14 employees
Funding: Seed rounds in 2022 totalling €350,000 (recorded investors include Coinvest Capital and Lithuanian Business Angel Network)
Hand tremors associated with neurological conditions (Essential Tremor, Parkinson's disease).
Medical devices / MedTech
50000 EUR
300000 EUR
Investors included Coinvest Capital and Lithuanian Business Angel Network
“Includes participation from Coinvest Capital and Lithuanian Business Angel Network”